Analysis: Profit growth rate of biopharmaceutical industry reached 70%

The business club was shortly before the 8th of October, led by the National Development and Reform Commission, the Ministry of Industry and Information Technology, the Ministry of Finance, and the Ministry of Science and Technology were participating in the “2010-2015 Biomedical Industry Revitalization Plan”. The relevant experts are now participating in the planning of the biomedical industry. Research and discussion. The new bio-pharmaceutical industry revitalization plan will be introduced at the end of the year, and it is expected to be included in the national "Twelfth Five-Year Plan" after its introduction.

According to Guo Fanli, a research fellow in the pharmaceutical industry of China Investment Advisors, in 2009, the total sales revenue of China's biopharmaceutical industry reached 75.3 billion yuan, which has made it one of the fastest growing areas in the pharmaceutical industry. At the same time, the profit growth rate of the biopharmaceutical industry is as high as 70%. This high growth rate and high profit growth rate have led to rapid growth in the biopharmaceutical industry.

Guo Fanli pointed out that in addition to the high profit growth rate, the support of policies will also greatly help the development of China's biomedical industry. In 2005, China issued the Outline of the National Medium- and Long-Term Scientific and Technological Development Plan (2006-2020). In 2008, the National Major Science and Technology Major Project was officially launched. By the end of 2009, China has promoted the promotion of the biological industry. "Some policies to speed up development" formally protect the development of the biomedical industry.

Zhang Yanlin, research director of China Investment Consulting Co., Ltd. pointed out that it is precisely because of this policy that China’s biopharmaceutical industry can support such a high growth rate. According to China’s target of around 2020, the total output value of bio-industries will reach 2.5-3 trillion, China’s biomedical The industry still has a long way to go. In order to achieve this goal, China must promote research and development of biopharmaceuticals, strengthen personnel training, improve technology reserves, and complement each other's resources in order to develop China's biopharmaceutical industry more comprehensively.

The "Investment Analysis and Forecast Report of China's Pharmaceutical Industry in 2010-2015" released by China Investment Advisors pointed out that in 2009, the proportion of China's bio-pharmaceutical industry in the entire pharmaceutical industry was only 10%, which also explains China's biomedical industry. The industry still has a vast space for development. With the steady advancement of the new healthcare reform and people’s emphasis on health and wellness, China’s biomedical industry will continue to lead the entire pharmaceutical industry in the future.